Probiotics and the immune landscape: An ally in breast cancer combination therapy
Nutrition · 2026
DOI: 10.1016/j.nut.2025.113011 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrition, 2026. Verfasst von Mohammad Amin Tokallou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran; Immunology Research Center, Mashhad University of Medical Sciences…. Hauptthemen laut MEDLINE: Probiotics, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 150 Literaturangaben. Gefördert von: Mashhad University of Medical Sciences.
Abstract (Originalsprache)
Breast cancer is the second cause of death among women in the world. Breast cancer deaths are anticipated to increase to 3.2 million by 2050. Although treatment methods such as surgery, chemotherapy, radiation, targeted therapies, and immunotherapy have advanced, survivors still face long-term problems. Probiotics are increasingly recognized as a promising therapeutic modality in cancer management, primarily through their capacity to modulate the gut microbiota and enhance host immune responses, in addition to their direct antitumor effects. Some probiotic strains also block cancer cell growth by promoting cancer cell apoptosis and reducing cell proliferation. Moreover, probiotics can also boost the effect of medications such as immune checkpoint inhibitors by boosting patients' immune systems against cancer cells. The objective of this review is to investigate the influence of probiotics on the immune system, their direct effects on cancer cells, and their potential in the treatment of breast cancer therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran; Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
- Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Immunology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
- Medical Laboratory Science Department, College of Science, University of Raparin, Rania, Sulaymaniyah, Iraq; Department of Medical Analysis, Faculty of Applied Science, Tishk International University, Erbil, Iraq.
- Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran; Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
- Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Immunology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: Imunoman2009@g…
Förderung
- Mashhad University of Medical Sciences
Zitieren
APA
Tokallou, M. A., Mahmoudi, M., Kheder, R. K., Azghadi, S. F., Rastgoo, E., Sabouri, A., & Esmaeili, S. A. (2026). Probiotics and the immune landscape: An ally in breast cancer combination therapy. Nutrition. https://doi.org/10.1016/j.nut.2025.113011
Vancouver
Tokallou MA, Mahmoudi M, Kheder RK, Azghadi SF, Rastgoo E, Sabouri A, et al. Probiotics and the immune landscape: An ally in breast cancer combination therapy. Nutrition. 2026. doi:10.1016/j.nut.2025.113011
BibTeX
@article{Tokallou2026,
author = {Tokallou, Mohammad Amin and Mahmoudi, Mahmoud and Kheder, Ramiar Kamal and Azghadi, Seyedeh Fatemeh and Rastgoo, Ehsan and Sabouri, Abbas and Esmaeili, Seyed Alireza},
title = {Probiotics and the immune landscape: An ally in breast cancer combination therapy},
journal = {Nutrition},
year = {2026},
doi = {10.1016/j.nut.2025.113011}
}
EUVIMED